UK's NICE updated guideline recommends progesterone to prevent early miscarriage News item 11 December 2021 Pages: 37 - 37
NICE recommends osimertinib for NSCLC within Cancer Drugs Fund News item 11 December 2021 Pages: 36 - 36
ICER posts draft scoping document for beta-thalassaemia treatment, betibeglogene autotemcel News item 11 December 2021 Pages: 35 - 35
ICER issues final evidence report for mavacamten for hypertrophic cardiomyopathy News item 11 December 2021 Pages: 34 - 34
Barriers to prescription drug access within US commercial insurance News item 11 December 2021 Pages: 33 - 33
Willingness to pay for cancer treatments and outcomes: QOL valued similarly to 1-year survival Clinical study 11 December 2021 Pages: 32 - 32
TB screening + treatment of young asylum seekers arriving in Germany may be cost effective Clinical study 11 December 2021 Pages: 31 - 31
T2DM patients associated with substantial specialist expenditure in the Netherlands Clinical study 11 December 2021 Pages: 30 - 30
Systemic sclerosis a significant patient and health resource economic burden Clinical study 11 December 2021 Pages: 29 - 29
Systematic review: population-based testing for hepatitis C may be a cost-effective strategy Clinical study 11 December 2021 Pages: 28 - 28
Systematic review: inconsistent methods for calculating informal care costs for dementia Clinical study 11 December 2021 Pages: 27 - 27
Supplementary DECT imaging cost effective for diagnosing occult hip fractures in Singapore Clinical study 11 December 2021 Pages: 26 - 26
Single-use clean intermittent catheters cost effective for managing neurogenic LUTD in Canada Clinical study 11 December 2021 Pages: 25 - 25
SGLT-2 inhibitors most cost effective for symptomatic and asymptomatic HFrEF Clinical study 11 December 2021 Pages: 24 - 24
Semaglutide + metformin not cost effective vs empagliflozin + metformin for T2DM in Denmark Clinical study 11 December 2021 Pages: 23 - 23
SAPIEN 3 TAVI cost effective vs surgical valve replacement for severe aortic stenosis in France Clinical study 11 December 2021 Pages: 22 - 22
Review of CEAs finds medical devices generally offer value for money Clinical study 11 December 2021 Pages: 21 - 21
Reimbursement and pricing for innovative drugs in France: identifying criteria to inform decision-making Non-clinical study 11 December 2021 Pages: 20 - 20
Radiation therapy cost-effective option for low-risk localised prostate cancer in Australia Clinical study 11 December 2021 Pages: 19 - 19
Population genomic screening of all Australian adults for FH could be cost effective Clinical study 11 December 2021 Pages: 18 - 18
Pembrolizumab + EP not cost effective vs EP as first-line treatment for SCLC in the USA Clinical study 11 December 2021 Pages: 17 - 17
Olaparib cost effective for in BRCA-mutated advanced ovarian carcinoma in Spain Clinical study 11 December 2021 Pages: 16 - 16
MRI plus targeted biopsy optimal choice for early detection of prostate cancer in Sweden Clinical study 11 December 2021 Pages: 15 - 15
Most cost effective strategy for para-aortic lymph node detection in LACC patients in Thailand? Clinical study 11 December 2021 Pages: 14 - 14
Monoclonal antibodies in metastatic colorectal cancer: benefits at high cost Review 11 December 2021 Pages: 13 - 13
Lifelong immunoglobulin replacement therapy for agammaglobulinaemia too costly in the USA Clinical study 11 December 2021 Pages: 12 - 12
Influenza vaccine cost effective in pregnant and older adults in Laos Clinical study 11 December 2021 Pages: 11 - 11
Indacaterol/glycopyrronium/mometasone cost effective in Canada Clinical study 11 December 2021 Pages: 10 - 10
Extending mammography screening to age 80 cost effective in USA? Clinical study 11 December 2021 Pages: 9 - 9
DTG-containing HIV treatments regimens appear to be cost effective in South Aftrica Clinical study 11 December 2021 Pages: 8 - 8
Domiciliary ventilation cost effective after hospitalisation for COPD Clinical study 11 December 2021 Pages: 7 - 7
Direct healthcare costs of patients with dyshidrotic eczema in the USA? Clinical study 11 December 2021 Pages: 6 - 6
Costs outside Swedish health system influence long-term value of DAA treatment for HCV Clinical study 11 December 2021 Pages: 5 - 5
Costs increase with AF burden in older patients with implantable devices Clinical study 11 December 2021 Pages: 4 - 4
Additional MRI more effective for initial staging in pancreatic cancer than standard imaging and less costly Clinical study 11 December 2021 Pages: 3 - 3
Concerns about rollout of inclisiran in primary care in England News item 11 December 2021 Pages: 2 - 2
UK's NICE has approved first long-acting injectable HIV treatment, cabotegravir with rilpivirine News item 27 November 2021 Pages: 36 - 36
NZ's Pharmac transitions to biosimilar adalimumab, Amgevita, to widen access News item 27 November 2021 Pages: 35 - 35
NICE draft guidance recommends oral risdiplam for SMA via managed access agreement News item 27 November 2021 Pages: 34 - 34
New ICER report shows highest US drug price increases not backed by clinical evidence News item 27 November 2021 Pages: 33 - 33
Latest NICE draft guidance does not recommend elusulfase alfa for rare disorder News item 27 November 2021 Pages: 32 - 32
Year-round influenza vaccination of pregnant women, young infants saves costs in Hong Kong Clinical study 27 November 2021 Pages: 31 - 31
WHO multi-dose vial policy for immunisation programme reduces wastage, saves costs in Egypt Clinical study 27 November 2021 Pages: 30 - 30
Venetoclax plus rituximab cost effective for CLL in Switzerland Clinical study 27 November 2021 Pages: 29 - 29
Universal HBV vaccination programme with antenatal HBsAg screening cost saving in Israel Clinical study 27 November 2021 Pages: 28 - 28
Tumour profiling to guide targeted lung cancer therapy not cost effective Clinical study 27 November 2021 Pages: 27 - 27
Treatment-resistant depression: high unmet need and economic burden in Belgium Clinical study 27 November 2021 Pages: 26 - 26
Treating major depressive disorder reduces costs of comorbid conditions Clinical study 27 November 2021 Pages: 25 - 25
TNF-α inhibitor persistence less costly in inflammatory arthritis Clinical study 27 November 2021 Pages: 24 - 24